Edgewise Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Edgewise Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Edgewise Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Edgewise Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $712k | 44k | 16.22 |
| 2025-06-30 | $575k | 44k | 13.11 |
| 2025-03-31 | $965k | 44k | 22.00 |
| 2024-12-31 | $1.2M | 45k | 26.70 |
| 2024-09-30 | $1.1M | 42k | 26.69 |
| 2024-06-30 | $761k | 42k | 18.01 |
| 2023-12-31 | $256k | 23k | 10.94 |
| 2023-09-30 | $134k | 23k | 5.73 |
| 2023-06-30 | $181k | 23k | 7.75 |
| 2023-03-31 | $156k | 23k | 6.67 |
| 2022-12-31 | $209k | 23k | 8.94 |
| 2022-09-30 | $230k | 23k | 9.84 |
| 2022-06-30 | $186k | 23k | 7.96 |
| 2022-03-31 | $227k | 23k | 9.70 |
| 2021-12-31 | $230k | 15k | 15.28 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors